6-Methyl-4-phenylchroman-2-one: A Key Fine Chemical Intermediate

Discover the properties, synthesis, and vital role of this compound in the fine chemical industry.

Get a Quote & Sample

Advantages Provided by the Product

Reliable Pharmaceutical Intermediate

Leveraging the properties of 6-Methyl-4-phenylchroman-2-one (CAS 40546-94-9) as a pharmaceutical intermediate ensures consistent quality and performance in drug manufacturing. This makes it a trusted component for companies focused on Tolterodine production.

Versatile in Organic Synthesis

The versatility of this compound in organic synthesis allows chemists to explore its use in creating a wide array of complex molecules. Its specific structure and reactivity are key to its utility as a valuable fine chemical intermediate.

Globally Accessible Sourcing

With multiple chemical suppliers of 40546-94-9 available worldwide, manufacturers can secure a steady supply chain for their production needs. This global accessibility is crucial for meeting market demands efficiently.

Key Applications

Pharmaceutical Synthesis

Central to its utility, this compound is a critical building block in the synthesis of pharmaceuticals, most notably as an intermediate for Tolterodine. Its precise chemical structure facilitates the creation of the final active pharmaceutical ingredient.

Organic Chemistry Research

Researchers in organic chemistry find this compound valuable for exploring new reaction pathways and developing novel molecules. Its well-defined chemical properties make it a reliable reagent for laboratory investigations.

Fine Chemical Manufacturing

In the broader fine chemical sector, it serves as an essential intermediate, contributing to the production of various specialized chemicals. Its availability from global suppliers ensures its integration into diverse manufacturing processes.

Drug Development

The role of 6-Methyl-4-phenylchroman-2-one in the Tolterodine production process highlights its significance in drug development. Manufacturers rely on such intermediates to streamline and optimize the creation of therapeutic agents.